Kyverna Therapeutics, Inc. SEC filings KYTX
Kyverna Therapeutics, Inc. has 187 filings in SEC EDGAR's recent list, going back to Oct 5, 2023. Its latest annual report, Form ARS, was filed on Apr 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 24, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Sep 24, 2026 | Sep 24, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Jul 27, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Material agreement
|
Jul 9, 2026 | Jul 8, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2026 | May 27, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
May 18, 2026 | May 14, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Other events
|
May 4, 2026 | May 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 22, 2026 | Apr 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 22, 2026 | Apr 21, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 20, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 3, 2026 | Jan 29, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Jan 12, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Dec 18, 2025 | Dec 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 15, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 15, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Material agreement, New debt, Regulation FD disclosure
|
Nov 3, 2025 | Nov 2, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 29, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 25, 2025 | Sep 19, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2025 | May 29, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Material agreement
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Other events
|
Jan 21, 2025 | Jan 21, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 26, 2024 | Nov 26, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 13, 2024 | Nov 8, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Oct 21, 2024 | Oct 20, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 16, 2024 | Sep 13, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 15, 2024 | Jul 15, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 14, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2024 | Mar 26, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Feb 12, 2024 | Feb 12, 2024 |
Showing 41 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- KYTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Emeryville, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1994702
- Former names
- Kyverna Therapeutics, Inc. (until Oct 19, 2026)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.